Results of forty years Yellow Card reporting for commonly used perioperative analgesic drugs

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 6, 2007, Pages 687-694

  Richardson, Jennifer ^a   Holdcroft, Anita ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Analgesics; Mortality; Pharmacovigilance

Indexed keywords

ALFENTANIL; ANALGESIC AGENT; ANESTHETIC AGENT; FENTANYL; KETOROLAC; MORPHINE; NALBUPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PETHIDINE; REMIFENTANIL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ARTICLE; ASTHMA; BLOOD CLOTTING DISORDER; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CONSCIOUSNESS DISORDER; CONSTIPATION; CONTROLLED STUDY; CONVULSION; DATA BASE; DEMOGRAPHY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DISEASE SEVERITY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ECG ABNORMALITY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HEMATEMESIS; HEMATOMA; HUMAN; HYPOTENSION; INFORMATION RETRIEVAL; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORBIDITY; MORTALITY; MUSCLE DISEASE; MYALGIA; NAUSEA AND VOMITING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; THORAX PAIN; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANALGESICS; DRUG HYPERSENSITIVITY; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; RESPIRATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 34447282854     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1403     Document Type: Article

References (30)

1. Zucker-Pinchoff B, Ramanathan S. Anaphylactic reaction to epidural feutanyl. Anesthesiology 1989; 71: 599-601.
2. Mertes PM, Laxenaire M-C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002; 19: 240-262.
3. Laxenaire PM-C, Mouton C, Moneret-Vautrin DA, et al. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicentre epidemiological inquiry. Ann Fr Anesth Reanim 1993; 12: 91-96.
4. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. Ann Fr Anesth Reanim 1993; 12: 97-104.
5. Clarke RSJ, Watkins J. Drugs responsible for anaphylactoid reactions in the United Kingdom. Ann Fr Anesth Reanim 1993; 12: 105-108.
6. www.dcs.shef.ac.uk/~barry/Pharmaco/Paper/node4.html (accessed 30th August 2005).
7. Mehta D (ed.). British National Formulary 49. British Medical Association & Royal Pharmaceutical Society of Great Britain: London, March 2005.
8. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. PD Safe 2001; 10: 483-486.
9. Farrow SC, Fowkes FG, Lunn JN, Robertson IB. Sweetnam P. Epidemiology in anaesthesia: a method for predicting hospital mortality. Eur J Anaesthesiol 1984; 1: 77-84.
10. Light KP, Lovell AT, Butt H, Fauvel NJ, Holdcroft A. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the UK: age and gender differences. PD Safe 2006; 15: 151-160.
11. http://www.nlm.nih.gov/medlineplus/ency/article/000844.htm (accessed 30th August 2005).
12. Rothman KJ, Lanes S, Sacks ST. The reporting odds ration and its advantages over the proportional reporting ration. PD Safe 2004; 13: 519-523.
13. Almenoff JS, Lacroix KK, Yuen NA, Fram D, Dumouchel W. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department. Drug Saf 2006; 29: 875-887.
14. Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. PD Safe 2005; 14: 285-286.
15. Waller P. Dealing with uncertainty in drug safety: lessons for the future from sertindole. PD Safe 2003; 12: 283-287.
16. Alvarez-Requejo A, Carvajal A, Bégaud B, Moride Y, Vega T, Martin Arias LH. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel study. Eur J Clin Pharmacol 1998; 54: 483-488.
17. Thiessard F, Roux E, Miremont-Salame G, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 2005; 28: 731-740.
18. Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28: 825-833.
19. van der Heijden PGM, van Puijenbroek EP, van Buuren S, van der Hofstede JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med 2002; 21: 2027-2044.
20. Freye E, Levy JW. Use of opioids in the elderly - pharmacokinetic and pharmacodynamic considerations. Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 527-537.
21. Bradley BA. Rejection and recipient age. Transpl Immunol 2002; 10: 125-132.
22. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18, 820 patients. Br Med J 2004; 329: 15-19.
23. Camu F, Lauwers MH, Vanlersberghe C. Side effects of NSAIDs and dosing recommendations for Ketorolac. Acta Anaesthesiol Belg 1996; 47: 143-149.
24. Chen AH, Bennett CR. Ketorolac-induced bronchospasm in an aspirin-intolerant patient. Anesth Prog 1994; 41: 102-107.
25. Sitenda GL, Ing EB, Van Dellen RG, Younge BR, Leavitt JA. Asthma caused by topical application of Ketorolac. Ophthalmology 1996; 103: 890-892.
26. Beers R, Camporesi E. Remifentanil update: clinical science and utility. CNS Drugs 2004; 18: 1085-1104.
27. Fujimoto T, Nishiyama T, Hanaoka K. Seizure induced by a small dose of fentanyl. J Anaesthesia 2003; 17: 55-56.
28. Knight B, Thomson N, Perry G. Seizures due to norpethidine toxicity. Aust N Z J Med 2000; 30: 513.
29. Fisher M. Treatment of acute anaphylaxis. Br Med J 1995; 311: 731-733.
30. Lau L, Jan G, Chan TF. Preparation of patients for anaesthesia - achieving quality care. Hong Kong Med J 2002; 8: 99-105.